BRAIN and NERVE Shinkei Kenkyu no Shinpo Volume 67, Issue 11 (November 2015)
Japanese

Target Molecule for a Demyelinating Type of Guillain-Barré Syndrome, Acute Inflammatory Demyelinating Polyneuropathy Masahiro Mori 1 1Department of Neurology, Graduate School of Medicine, Chiba University Keyword: ギラン・バレー症候群 , 急性炎症性脱髄性多発ニューロパチー , 標的分子 , モエシン , サイトメガロウイルス , Guillain-Barré syndrome , acute inflammatory demyelinating polyneuropathy , target molecule , moesin , cytomegalovirus pp.1359-1369
Published Date 2015/11/1
DOI https://doi.org/10.11477/mf.1416200306
  • Abstract
  • Look Inside
  • Reference

Abstract

Guillain-Barré syndrome is classified into demyelinating type, acute inflammatory demyelinating polyneuropathy (AIDP) and axonal form, acute axonal motor neuropathy (AMAN). It has been clearly established that the target molecule for the former is a ganglioside. In contrast, despite years of effort, the target molecule for the latter has not been identified. Recently, molecules around the nodes of Ranvier have entered the spotlight, and "moesin" was reported to be a target molecule for cytomegalovirus associated-AIDP.


Copyright © 2015, Igaku-Shoin Ltd. All rights reserved.

基本情報

18816096.67.11.jpg
BRAIN and NERVE-神経研究の進歩
67巻11号 (2015年11月)
電子版ISSN 1344-8129 印刷版ISSN 1881-6096 医学書院

関連文献

もっと見る

文献を共有